Updated Jul 16, 2026
ORLOFF JOHN J has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
John J. Orloff is listed as a director of Zenas BioPharma, Inc. according to the most recent SEC filing dated 2026-06-17. Publicly available biographical details beyond his board role are not provided in the filing, and there is no additional confirmed information in this context about his career history, education, or other board affiliations. Further background would typically be found through company disclosures, press releases, or professional profiles.
| Role | Director |
|---|---|
| Notability | 40/100 |
John J. Orloff is listed as a director of Zenas BioPharma, Inc. according to the most recent SEC filing dated 2026-06-17. Publicly available biographical details beyond his board role are not provided in the filing, and there is no additional confirmed information in this context about his career history, education, or other board affiliations. Further background would typicall…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ORLOFF JOHN J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.